Visual field progression outcomes in glaucoma subtypes

Acta Ophthalmologica

Volumn 91, Issue 3, 2013, Pages 288-293

  De Moraes, Carlos Gustavo ^a,b,c   Liebmann, Jeffrey M ^a,b   Liebmann, Craig A ^a   Susanna, Remo ^c   Tello, Celso ^a,d   Ritch, Robert ^a,d  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

glaucoma; intraocular pressure; phenotype; risk factors; visual field progression

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; COHORT ANALYSIS; DISEASE COURSE; EXFOLIATIVE GLAUCOMA; FEMALE; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; GONIOSCOPY; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; LASER SURGERY; LINEAR REGRESSION ANALYSIS; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; OPEN ANGLE GLAUCOMA; PERIMETRY; PHENOTYPE; PIGMENT GLAUCOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL FIELD; VISUAL THRESHOLD;

EID: 84876351455     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02260.x     Document Type: Article

References (30)

1. AGIS Investigators (2000): The Advanced Glaucoma Intervention Study (AGIS) 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 490-491.
2. Ahrlich K, De Moraes CG, Teng CC, Prata TS, Tello C, Ritch R, &, Liebmann JM, (2009): Visual field progression differences between normal-tension and exfoliative high-tension glaucoma patients. Invest Ophthalmol Vis Sci 51: 1458-1463.
3. Airaksinen PJ, Mustonen E, &, Alanko HI, (1981): Optic disc hemorrhages. Analysis of stereophotographs and clinical data of 112 patients. Arch Ophthalmol 99: 1795-1801.
4. Bengtsson B, Leske MC, Yang Z, Heijl A, & EMGT Group (2008): Disc hemorrhages and treatment in the early manifest glaucoma trial. Ophthalmology 115: 2044-2048.
5. Budenz DL, Anderson DR, Feuer WJ, et al., (2006): Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113: 2137-2143.
6. Chauhan BC, Garway-Heath DF, Goñi FJ, Rossetti L, Bengtsson B, Viswanathan AC, &, Heijl A, (2008): Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 92: 569-573.
7. De Moraes CG, Prata TS, Tello C, Ritch R, &, Liebmann JM, (2009): Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression. Arch Ophthalmol 127: 1129-1134.
8. De Moraes CG, Ritch R, &, Liebmann JM, (2010): Bridging the major prospective national eye institute-sponsored glaucoma Clinical Trials and Clinical Practice. J Glaucoma 20: 1-2.
9. De Moraes CG, Juthani V, Liebmann JM, Teng CC, Tello C, Susanna R Jr, &, Ritch R, (2011): Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol 129: 562-568.
10. Drance S, Anderson DR, &, Schulzer M, (2001): Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131: 699-708.
11. Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, &, Crabb DP, (1996): Analysis of visual field progression in glaucoma. Br J Ophthalmol 80: 40-48.
12. Folgar FA, de Moraes CG, Prata TS, Teng CC, Tello C, Ritch R, &, Liebmann JM, (2010): Glaucoma surgery decreases the rates of localized and global visual field progression. Am J Ophthalmol 149: 258-264.
13. Forchheimer I, de Moraes CG, Teng CC, Folgar F, Tello C, Ritch R, &, Liebmann JM, (2011): Baseline mean deviation and rates of visual field change in treated glaucoma patients. Eye (Lond) 25: 626-632.
14. Gardiner SK, &, Crabb DP, (2002): Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci 43: 1400-1407.
15. Gordon MO, Beiser JA, Brandt JD, et al., (2002): The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 714-720.
16. Grødum K, Heijl A, &, Bengtsson B, (2005): Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology 112: 386-390.
17. Heijl A, Bengtsson B, Hyman L, &, Leske MC, (2009): Natural history of open-angle glaucoma. Early Manifest Glaucoma Trial Group. Ophthalmology 116: 2271-2276.
18. Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA, & the Ocular Hypertension Treatment Study Group (2004): The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol 122: 813-820.
19. Jonas JB, &, Iester M, (1995): Disc hemorrhage and glaucoma. Ophthalmology 102: 365-366.
20. Jonas JB, Nguyen XN, Gusek GC, &, Naumann GO, (1989): Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci 30: 908-918.
21. Jonas JB, Martus P, Horn FK, Jünemann A, Korth M, &, Budde WM, (2004): Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss. Invest Ophthalmol Vis Sci 45: 2613-2618.
22. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, & EMGT Group (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114: 1965-1972.
23. Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I, & EGPS Group (2007): Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Am J Ophthalmol 144: 266-275.
24. Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK, & CIGTS Study Investigators (2009): Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology 116: 200-207.
25. Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli J, & Advanced Glaucoma Intervention Study (2004): Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111: 1627-1635.
26. Prata TS, De Moraes CG, Teng CC, Tello C, Ritch R, &, Liebmann JM, (2010): Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage. Ophthalmology 117: 24-29.
27. Quigley HA, Enger C, Katz J, Sommer A, Scott R, &, Gilbert D, (1994): Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 112: 644-649.
28. Ritch R, (2008): The management of exfoliative glaucoma. Prog Brain Res 173: 211-224.
29. Spry PG, Bates AB, Johnson CA, &, Chauhan BC, (2000): Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci 41: 2192-2200.
30. Teng CC, De Moraes CG, Prata TS, Tello C, Ritch R, &, Liebmann JM, (2010): Beta-zone parapapillary atrophy and the velocity of glaucoma progression. Ophthalmology 117: 909-915.